We are committed to provide high quality & cost-effective preclinical services with faster turnaround times
Comprehensive services including study design and advanced data analysis.
Partnerships with certified labs across EU and US, providing access to specialized expertise and cutting-edge resources.
dedicated Study Director and Laboratory Technician assigned to your project.
Routine bi-weekly or monthly updates ensure clients are informed every step of the way.

Established & customized in vivo studies across a wide range of therapeutic areas, including cardiovascular, oncology, neurology, metabolic disorders, and more. Leveraging our extensive expertise in translational research to accelerate your pipeline.
State-of-the-art cell-based assays, immunoassays, and high-throughput screening capabilities to comprehensively evaluate your compounds' safety and efficacy. Our multidisciplinary expertise spans regenerative medicine, microbiome research, and beyond.
Strategic guidance to navigate the clinical development journey, from study design and feasibility assessments to seamless operational execution during early-stage trials. We partner with you to transform innovative ideas into sustainable health solutions.


Accelerating Drug Development with Regulatory-Compliant Preclinical Testing
Our GLP-compliant in vivo studies adhere to FDA, EMA, and OECD guidelines, ensuring the highest standards of quality, safety, and documentation for regulatory approval.
✔️ Single & repeat-dose toxicity
✔️ Carcinogenicity & genotoxicity
✔️ Reproductive toxicology
✔️ Safety pharmacology
🔹 Pathology & toxicokinetics evaluations
🔹 Integrated data interpretation for regulatory submissions
🔹 Comprehensive IND-supporting reports

Alzheimer’s, Parkinson’s, ALS, Spinal Cord Injury
Comprehensive in vivo models to study disease progression and therapeutic interventions.
Robust models for evaluating novel pain management and neuroprotective therapies.
Middle Cerebral Artery Occlusion (MCAO), Photothrombotic Stroke
Clinically relevant models for assessing neurovascular dysfunction and recovery strategies.
Precision models to evaluate nerve regeneration and neurorehabilitation approaches.

✔ Genetically engineered mice with specific cancer mutations
✔ Ideal for studying tumor-immune system interactions and immunotherapies
✔ Human tumor cells implanted into immunodeficient mice
✔ Reliable platform for evaluating anti-cancer drug efficacy
✔ Directly derived from patient tumor tissue
✔ Highly predictive models for personalized medicine & translational research

Cutting-edge tumoroid and spheroid models derived from minimal samples, covering diverse cancer types.
low-based culture systems that better replicate the human body compared to traditional static models.
Evaluate oncology drugs, biologics, radiotherapy, and emerging therapies with high precision.
With 95% of cancer drugs failing in clinical trials, our 3D cell culture models provide more reliable, predictive insights by preserving the tumor microenvironment.

✔ Clinically relevant models for Crohn’s disease & ulcerative colitis
✔ Evaluating novel anti-inflammatory & immunomodulatory therapies
✔ Food allergies, allergic asthma, and rhinitis
✔ Preclinical testing for desensitization strategies & targeted treatments
✔ Rheumatoid arthritis, systemic lupus erythematosus (SLE), multiple sclerosis
✔ Investigating disease mechanisms & immune-targeted therapies

Type 1 & Type 2 diabetes models for evaluating novel insulin therapies and glucose regulation strategies.
Induced by high-fat diets & genetic modifications, mimicking human metabolic dysfunction.
Clinically relevant models for non-alcoholic fatty liver disease, supporting drug development and lifestyle intervention studies.

Rodent models for vascular regeneration and perfusion recovery, aiding in therapeutic angiogenesis research.
Genetically modified mouse models to study plaque formation, lipid metabolism, and therapeutic interventions.
Models developed through genetic and dietary manipulations, mimicking human hypertensive conditions.
Preclinical models induced by pressure overload and myocardial infarction, supporting drug discovery and regenerative therapies.

Clinically relevant models for studying pneumonia, sepsis, and antimicrobial therapies.
reclinical models for investigating HIV, hepatitis, and antiviral drug efficacy..
Malaria and other parasitic diseases, supporting the development of novel therapeutics.
Exploring the role of the microbiome in health and disease, with models for gut, skin, and systemic microbiome studies.

Models induced by elevated intraocular pressure, mimicking disease progression and neurodegeneration.
Preclinical models for both dry and wet AMD, supporting drug discovery and intervention strategies.
Models replicating proliferative and non-proliferative diabetic retinopathy, enabling evaluation of novel therapies.

Genetically modified mice with targeted mutations in longevity-related genes to study lifespan extension and aging mechanisms.
Caloric restriction and dietary interventions to explore the impact of metabolism on aging and age-related diseases.
🔹 Cutting-edge models for aging and longevity research
🔹 Supporting the development of novel anti-aging therapies
